MeSH tree: C12.050.351.937.418.685
A new study from The Wistar Institute has uncovered an unexpected link between fructose—a common dietary sugar—and the spread of an aggressive form of ovarian cancer. Published in Nature Aging, the study found that cancer ...
Jul 30, 2026
0
1065
Researchers at The University of Texas MD Anderson Cancer Center have discovered a strategy to overcome PARP inhibitor resistance in ovarian cancer, one of the most common barriers to the long-term effectiveness of this widely ...
Jul 30, 2026
0
5
The composition of donor cord blood may play a critical role in the success of chimeric antigen receptor (CAR) natural killer (NK) cell therapies. A small population of immature NK cells present in donor cord blood can undermine ...
Jul 29, 2026
0
1
Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against ovarian cancer in preclinical studies. It's a major development for this type of immunotherapy, which has been used ...
Jul 19, 2026
0
11
Some people inherit genetic changes that put them at higher risk of developing certain cancers or heart disease. A simple genetic test can identify those risks early, creating opportunities to prevent disease or detect it ...
Jul 13, 2026
0
4
Two in five women with ovarian cancer are diagnosed only after an emergency hospital admission, when they are three times less likely to have early-stage and potentially curable disease, finds a data analysis published in ...
Jul 7, 2026
0
4
When Mayo Clinic researchers sequenced the genomes of 484 seemingly healthy adults, they found that about 13% carried a serious, previously unrecognized genetic risk—conditions those patients did not know about and that standard ...
May 14, 2026
0
4
A new scoping review from the University of Toronto reveals that caregivers of loved ones with ovarian cancer face significant emotional strain, heavy caregiving responsibilities, and limited support throughout the disease ...
Apr 30, 2026
0
3
Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in comprehensive genomic profiling ...
Mar 31, 2026
0
5
Stress is a constant companion in the oncologist's office. It appears at the time of diagnosis, increases with each stage of treatment, and often does not resolve even after therapy formally ends. It accompanies therapeutic ...
Mar 24, 2026
0
13
